Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 39 filings.
19 Aug 2026 1 filing
Business overview
Core products: ethanolamines, alkyl alkanolamines, morpholine derivatives, gas-treating solvents.
Cater to oil refining, petrochemicals, pharma, agrochemicals, textiles.
Exports to 85+ countries.
Capacity: 32,760 MTPA at Turbhe; multi-location manufacturing.
R&D: DSIR-recognized; 43 new products in five years.
Operational highlights
FY26 revenue mix: Gas Treating, Alkanolamines, Morpholine contributed meaningfully.
Unit 01 utilization 85% in FY26; Unit 02 60%; Unit 03 45%.
Two integrated facilities across 56 acres with expansion potential.
Q1FY27 revenue ₹150.53 Cr; EBITDA ₹15.14 Cr.
Q1FY27 EBITDA margin 10.06%.
Financial performance
FY26 revenue from operations ₹571.03 Cr; FY25 ₹660.73 Cr.
Total income FY26 ₹571.75 Cr.
EBITDA ₹60.49 Cr; margin 10.59%.
Net profit ₹36.53 Cr; EPS ₹6.64.
Profit before tax ₹49.37 Cr.
Capital structure & liquidity
Total equity ₹292.26 Cr; long-term borrowings ₹11.56 Cr.
Current liabilities ₹109.41 Cr; short-term borrowings ₹15.65 Cr.
Cash and cash equivalents ₹49.22 Cr at FY26 end.
Operating cash flow positive in FY23–FY26; balance sheet improving.
Strategic priorities & outlook
FY27 started strong; inventory gains supported profitability.
Partial plant operations due to fuel/gas constraints; prices passed where possible.
Firm order book supports profitability; pursuing export opportunities.
Agreements with two global MNCs to supply formulated solvents.
No formal guidance provided.
Risks & mitigation
Geopolitical and supply-chain disruptions affecting inputs and deliveries.
Rising input costs; some tender pricing fixed; passthrough where feasible.
Middle East shipments suspended briefly; resumed on no-credit terms.
Governance & leadership
Board: 6 members; 2 executive, 3 independent; 2 women directors.
Chairman: Hemant Kumar Ruia; Executive Director: Yashvardhan Ruia.
Committees: Audit, Stakeholder Relationship, CSR, Nomination & Remuneration.
DSIR-recognized in-house R&D lab; 43 new products developed.
14 Aug 2026 2 filings
Dividend record date and e-voting
Record date: Friday, September 11, 2026 for dividend eligibility.
Dividend amount: Rs 0.50 per equity share (face Rs 2, 25%).
Payments to demat holders as of Sept 11; physical transfers by Sept 11.
Cut-off date for e-voting: Wednesday, September 16, 2026.
AGM date: September 23, 2026; dividend subject to shareholder approval.
Dividend payment subject to deduction of tax at source.
Standalone results
Revenue from Operations: 15,052.51 lakhs.
Total Income: 15,071.93 lakhs.
Profit before Tax: 1,278.15 lakhs.
Tax Expense: 327.34 lakhs.
Profit for the period: 950.81 lakhs.
EPS: 1.73.
Unaudited standalone results; limited review with unmodified opinion.
Single segment; Ind AS-108 not applicable.
Results available on amines.com and BSE/NSE.
Consolidated results
Consolidated Revenue from Operations: 15,052.51 lakhs.
Consolidated Total Income: 15,072.40 lakhs.
Consolidated PBT: 1,273.92 lakhs.
Consolidated Tax Expense: 327.34 lakhs.
Consolidated Profit for the period: 946.58 lakhs.
Consolidated EPS: 1.72.
Unaudited consolidated results; limited review with unmodified opinion.
Board decisions & AGM timeline
51st AGM on Sep 23, 2026 via VC/OAVM.
Record date Sep 11, 2026 for final dividend if approved.
Cut-off date Sep 16, 2026 for voting.
6 Aug 2026 1 filing
Meeting Details
Board meeting scheduled for August 14, 2026; time and venue not disclosed.
Key Agenda Items
Unaudited standalone and consolidated quarterly results for June 30, 2026, with Limited Review Report.
Other Notes
Trading window closed till August 16, 2026 following outcome submission.
10 Jul 2026 1 filing
Dematerialisation confirmation
Dematerialisation requests processed during the quarter; accepted/rejected by the registrar.
Securities dematerialised listed on stock exchanges where the issuer's earlier securities are listed.
Physical certificates for dematerialisation mutilated and cancelled; depository name substituted as registered owner within timelines.
1 Jul 2026 1 filing
Transfer to IEPF
Final dividend for FY 2018-19 unclaimed for seven years will be transferred to IEPF on Oct 28, 2026.
Shares with seven consecutive years of unclaimed dividends will be transferred to IEPF on Oct 28, 2026.
Notice to shareholders issued July 1, 2026, informing about transfer and claim deadline.
Claim process and deadlines
Shareholders may claim by Oct 13, 2026, through prescribed forms and entitlement letter.
For physical shares, duplicate certificates issued; for demat, demat account debited.
Claims require IEPF-5 web form submission with enumerated supporting documents.
KYC-compliance required; fund transfers depend on folio being KYC compliant.
Contacts: Amines & Plasticizers Company Secretary and MUFG Intime for assistance.